![Christopher Brennan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Mark Goldberg | M | 64 |
Allucent
![]() Allucent Pharmaceuticals: OtherHealth Technology Allucent is a clinical research organization that provides comprehensive drug development solutions to small and mid-sized biotech companies. The private company is based in Cary, NC, and was founded in 2022. With over 30 years of experience in more than 60 countries, the company offers consulting, clinical operations, biometrics, and clinical pharmacology services across various therapeutic areas. Allucent's individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients. Mark A. Goldberg has been the CEO of the company since 2018. | 6 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 1 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Christopher Brennan
- Réseau Personnel